Cargando…

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes

OBJECTIVES: Whole genome expression profiles allow the stratification of bladder urothelial carcinoma into basal and luminal subtypes which differ in histological patterns and clinical behavior. Morpho-molecular studies have resulted in the discovery of immunohistochemical markers that might enable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravanini, Juliana Naves, Assato, Aline Kawassaki, Wakamatsu, Alda, Alves, Venâncio Avancini Ferreira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050602/ https://www.ncbi.nlm.nih.gov/pubmed/33909826 http://dx.doi.org/10.6061/clinics/2021/e2587

Ejemplares similares

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
por: Dhawan, Deepika, et al.
Publicado: (2018)

Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer
por: Dhawan, Deepika, et al.
Publicado: (2015)

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
por: Reis, Leonardo Oliveira
Publicado: (2016)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications
por: Barth, Isabella, et al.
Publicado: (2018)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes
por: Feng, Chao, et al.
Publicado: (2021)

Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors
por: Sohn, Yu-Mee, et al.
Publicado: (2016)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer
por: Mandelli, Giulio Eugenio, et al.
Publicado: (2020)

Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression
por: Jung, Minsun, et al.
Publicado: (2020)

Molecular pathology of the luminal class of urothelial tumors
por: Bernardo, Carina, et al.
Publicado: (2019)

Correlating Tumor Stiffness with Immunohistochemical Subtypes of Breast Cancers: Prognostic Value of Comb-Push Ultrasound Shear Elastography for Differentiating Luminal Subtypes
por: Denis, Max, et al.
Publicado: (2016)

Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years
por: Weyerer, Veronika, et al.
Publicado: (2017)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy
por: Schnitzler, Tician, et al.
Publicado: (2020)

Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study
por: Florianova, Livia, et al.
Publicado: (2015)

MEK is a promising target in the basal subtype of bladder cancer
por: Merrill, Nathan M., et al.
Publicado: (2020)

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers
por: Kim, Doris, et al.
Publicado: (2016)

Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression
por: Abubakar, Mustapha, et al.
Publicado: (2019)

Correlation between Immunohistochemical Subtype and Clinicopathological Features in Patients with Diffuse Large B-cell Lymphoma
por: PATRASCU, ANA-MARIA, et al.
Publicado: (2017)

Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
por: Jia, Rong, et al.
Publicado: (2020)

Phenotypic and immunohistochemical characterization of sarcoglycanopathies
por: Ferreira, Ana F. B., et al.
Publicado: (2011)

Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma
por: Kim, Bohyun, et al.
Publicado: (2021)

Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer
por: Abbas, Mahmoud, et al.
Publicado: (2023)

Luminal DMSO: Effects on Detrusor and Urothelial/Lamina Propria Function
por: Smith, Katrina J., et al.
Publicado: (2014)

Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma
por: Feng, Chenchen, et al.
Publicado: (2014)

Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder
por: Mumtaz, Shazia, et al.
Publicado: (2020)

Differentiation‐associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic‐metabolizing activity of “luminal” muscle‐invasive bladder cancers
por: Baker, Simon C., et al.
Publicado: (2018)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco
por: El Fatemi, Hinde, et al.
Publicado: (2012)

Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
por: Goutas, Dimitrios, et al.
Publicado: (2022)

Basal Cell Adenoma-Clinicopathological, Immunohistochemical Analysis and Surgical Considerations of a Rare Salivary Gland Tumor with Review of Literature
por: Bhagat Singh, AD, et al.
Publicado: (2015)

Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors
por: Wang, Hui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_svrggvdj869faisjm9ha4v65l1